
zzso zzso for the treatment of cancer has met with limited but, for some, encouraging zzso A minority of zzso melanoma and zzso cell zzso patients respond to therapy with zzso 2 zzso or zzso plus zzso killer zzso zzso The mechanism of response, and the reasons for the variation within disease groups, is not zzso In this article, zzso zzso proposes that successful adoptive therapy is dependent on the recruitment of activated host zzso T zzso and suggests that this explains the greater efficacy of zzso zzso in combating melanoma and zzso cell zzso 

